Cargando…

p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild‐type p53

Tumor suppressor p53 is a master regulator of apoptosis and plays key roles in cell cycle checkpoints. p53 responds to metabolic changes and alters metabolism through several mechanisms in cancer. Lactate dehydrogenase A (LDHA), a key enzyme in glycolysis, is highly expressed in a variety of tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yao, Niu, Weihong, Luo, Yanwei, Li, Hui, Xie, Yong, Wang, Heran, Liu, Yukun, Fan, Songqing, Li, Zheng, Xiong, Wei, Li, Xiaoling, Ren, Caiping, Tan, Ming, Li, Guiyuan, Zhou, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398928/ https://www.ncbi.nlm.nih.gov/pubmed/30618169 http://dx.doi.org/10.1111/cas.13928

Ejemplares similares

BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild-type P53
por: Luo, Yanwei, et al.
Publicado: (2022)

BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition
por: Niu, Weihong, et al.
Publicado: (2020)

BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2018)

Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2019)

METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
por: Hou, Yichao, et al.
Publicado: (2023)

Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function
por: Sheppard, Sam, et al.
Publicado: (2021)

Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway
por: Xie, Haibiao, et al.
Publicado: (2021)

Bromodomain-containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2-antagonist/killer protein
por: Ma, Jinqi, et al.
Publicado: (2019)

IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer
por: Liu, Min, et al.
Publicado: (2020)

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
por: Billiard, Julia, et al.
Publicado: (2013)

H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis
por: Sun, Linqing, et al.
Publicado: (2021)

Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1
por: Wang, Yueyuan, et al.
Publicado: (2022)

Functional Diversity of p53 in Human and Wild Animals
por: Li, Yi, et al.
Publicado: (2019)

BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141
por: Liu, Yukun, et al.
Publicado: (2018)

Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer
por: Wang, Jian, et al.
Publicado: (2015)

LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer
por: Wang, Wei, et al.
Publicado: (2022)

p53-regulated autophagy is controlled by glycolysis and determines cell fate
por: Duan, Lei, et al.
Publicado: (2015)

MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis
por: Guo, Jinan, et al.
Publicado: (2019)

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities
por: Li, Ping, et al.
Publicado: (2021)

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
por: Ding, Jie, et al.
Publicado: (2022)

The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
por: Li, Dan-Dan, et al.
Publicado: (2012)

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
por: Szybka, M, et al.
Publicado: (2008)

Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
por: Trinidad, Antonio Garcia, et al.
Publicado: (2013)

Early Biomarkers Associated with P53 Signaling for Acute Radiation Injury
por: Li, Weihong, et al.
Publicado: (2022)

p53 β-hydroxybutyrylation attenuates p53 activity
por: Liu, Kun, et al.
Publicado: (2019)

Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells
por: Qi, Yuehua, et al.
Publicado: (2022)

Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
por: Zhao, Kai, et al.
Publicado: (2015)

P55PIK Regulates P53-Dependent Apoptosis in Cancer Cells by Interacting with P53 DNA-Specific Domain
por: Li, Chaoxing, et al.
Publicado: (2020)

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
por: Bourdon, Jean-Christophe, et al.
Publicado: (2011)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)

Conversion of Fibroblasts to Neural Cells by p53 Depletion
por: Zhou, Di, et al.
Publicado: (2014)

OTUD5 Regulates p53 Stability by Deubiquitinating p53
por: Luo, Judong, et al.
Publicado: (2013)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
por: Zhao, Kai, et al.
Publicado: (2019)

p53 Amino-Terminus Region (1–125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype
por: Sharma, Anuj Kumar, et al.
Publicado: (2009)

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells
por: Mortensen, Anja Charlotte Lundgren, et al.
Publicado: (2019)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

The Proteasome Activator PA28γ, a Negative Regulator of p53, Is Transcriptionally Up-Regulated by p53
por: Wan, Zhen-Xing, et al.
Publicado: (2014)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

p53‐TP53‐Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells
por: Li, Xue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fn6lc6jlth7thjaf02ci16nvsq